Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults

INTRODUCTION: In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We adapted the Brighton Collaboration list to evaluate serious adverse events of special...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraiman, Joseph, Erviti, Juan, Jones, Mark, Greenland, Sander, Whelan, Patrick, Kaplan, Robert M., Doshi, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/
https://www.ncbi.nlm.nih.gov/pubmed/36055877
http://dx.doi.org/10.1016/j.vaccine.2022.08.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/
https://www.ncbi.nlm.nih.gov/pubmed/36055877
http://dx.doi.org/10.1016/j.vaccine.2022.08.036

Ejemplares similares